Accelerated aging — when someone’s biological age is greater than their chronological age — could increase the risk of cancer tumors. That’s according to new research presented this week at the ...

The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?

Madrigal Pharmaceuticals, Inc. dual surrogate Primary endpoint being met in phase 3 MAESTRO-NASH study allowed for the rolling NDA submission of resmetirom for the treatment of patients with NASH.

New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that one's biological age, which can be higher than his or her chronological age – ...

People struggling to pay for basic needs such as food, housing, and medical care face a sharply higher risk of death.

Less than half of the cancer therapies that were granted accelerated approval by the FDA between 2013 and 2017 showed a clinical benefit in a confirmatory trial within the next five years. That is the ...

(WTHR) — A large study of brain scans has yielded surprising results for researchers: cannabis use is one of the leading factors of accelerated brain aging. The study, published by the Journal of ...

High-school courses that let students pursue advanced study in mathematics and science should be more in-depth, and should also be made more widely available to poor and minority students, a report ...

A new study highlights a crucial biosphere feedback mechanism and its effects on releasing soil carbon into the atmosphere. A first-of-its-kind study led by researchers at the University of Oklahoma ...

Dec. 3 (UPI) --Annual spending on drugs granted accelerated approval by the Food and Drug Administration increased significantly over the past half decade, a study published Friday by JAMA Health ...

A new study by Yale anthropologists has uncovered the first evidence that childbearing may cause accelerated aging in women. The researchers tested 100 healthy postmenopausal women from five rural ...

The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?